Lynn E Sullivan

Summary

Affiliation: Yale University
Country: USA

Publications

  1. doi request reprint A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Am J Addict 20:343-56. 2011
  2. ncbi request reprint Hepatitis C and HIV infections: implications for clinical care in injection drug users
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
    Am J Addict 13:1-20. 2004
  3. pmc Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Subst Abuse Treat 35:87-92. 2008
  4. pmc Narrative review: buprenorphine for opioid-dependent patients in office practice
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Ann Intern Med 148:662-70. 2008
  5. pmc The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients
    Lynn E Sullivan
    Yale University School of Medicine, 367 Cedar Street, New Haven, CT 06520, USA
    Addiction 103:1461-7. 2008
  6. pmc The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Am J Addict 19:53-8. 2010
  7. pmc The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    J Acquir Immune Defic Syndr 56:S54-61. 2011
  8. pmc Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, CT 06520 8093, United States
    Drug Alcohol Depend 117:158-63. 2011
  9. ncbi request reprint The case for routine HIV screening and impact of managed care
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    Am J Manag Care 16:S345-51. 2010
  10. ncbi request reprint Training HIV physicians to prescribe buprenorphine for opioid dependence
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 6520 8025, USA
    Subst Abus 27:13-8. 2006

Detail Information

Publications38

  1. doi request reprint A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Am J Addict 20:343-56. 2011
    ..4 (95% CI = .3- 2.4) fewer standard drinks per week compared to control (p = .012). Nonphysician brief interventions are modestly effective at reducing drinking in primary care patients with unhealthy alcohol use...
  2. ncbi request reprint Hepatitis C and HIV infections: implications for clinical care in injection drug users
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
    Am J Addict 13:1-20. 2004
    ..Providers caring for patients who are or were IDUs must be aware of the management of these diseases and make efforts to integrate their medical care with the treatment of their substance abuse...
  3. pmc Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Subst Abuse Treat 35:87-92. 2008
    ..We conclude that primary-care-based buprenorphine/naloxone treatment is associated with decreased drug-related HIV risk, but additional efforts may be needed to address sex-related HIV risk when present...
  4. pmc Narrative review: buprenorphine for opioid-dependent patients in office practice
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Ann Intern Med 148:662-70. 2008
    ..The different components of treatment; the role of the physician who provides this treatment; and the logistics of treating this growing, multifaceted patient population are also examined...
  5. pmc The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients
    Lynn E Sullivan
    Yale University School of Medicine, 367 Cedar Street, New Haven, CT 06520, USA
    Addiction 103:1461-7. 2008
    ..To examine the impact of alcohol use on depressive symptoms in human immunodeficiency virus (HIV)-infected patients...
  6. pmc The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Am J Addict 19:53-8. 2010
    ..35%, p = .001). We conclude that both baseline and in-treatment cocaine use is associated with worse treatment outcomes in patients receiving office-based buprenorphine/naloxone and may benefit from targeted interventions...
  7. pmc The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    J Acquir Immune Defic Syndr 56:S54-61. 2011
    ..Cocaine use is common in opioid-dependent HIV-infected patients, but its impact on treatment outcomes in these patients receiving buprenorphine/naloxone is not known...
  8. pmc Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, CT 06520 8093, United States
    Drug Alcohol Depend 117:158-63. 2011
    ..The impact of alcohol consumption on depressive symptoms over time among patients who do not meet criteria for alcohol abuse or dependence is not known...
  9. ncbi request reprint The case for routine HIV screening and impact of managed care
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    Am J Manag Care 16:S345-51. 2010
    ..Given the public health impact of HIV infection, federal and private partnerships should be considered to establish routine HIV screening practices...
  10. ncbi request reprint Training HIV physicians to prescribe buprenorphine for opioid dependence
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 6520 8025, USA
    Subst Abus 27:13-8. 2006
    ..HIV physicians' concerns regarding interactions between buprenorphine and HAART need to be addressed in future training efforts...
  11. ncbi request reprint Initial strategies for integrating buprenorphine into HIV care settings in the United States
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Clin Infect Dis 43:S191-6. 2006
    ....
  12. ncbi request reprint Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
    Clin Infect Dis 41:891-6. 2005
    ..This review addresses the introduction of buprenorphine, in terms of public health, policy, and clinical implications for HIV-infected patients and for HIV care providers...
  13. ncbi request reprint The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, P O Box 208025, New Haven, CT 06520 8025, USA
    Drug Alcohol Depend 79:113-6. 2005
    ..Treatment outcomes with buprenorphine in a PCC do not vary based on history of prior methadone treatment...
  14. ncbi request reprint The prevalence and impact of alcohol problems in major depression: a systematic review
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA
    Am J Med 118:330-41. 2005
    ..In addition, the literature focuses almost exclusively on patients with alcohol abuse or dependence in psychiatric inpatient settings, and excludes patients with less severe alcohol problems and primary care outpatient settings...
  15. ncbi request reprint A trial of integrated buprenorphine/naloxone and HIV clinical care
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Clin Infect Dis 43:S184-90. 2006
    ..We investigated the feasibility and efficacy of integrating buprenorphine, along with 2 levels of counseling, into HIV clinical care...
  16. ncbi request reprint Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Addiction 100:150-8. 2005
    ..To examine the role of expanded access to opioid agonist treatment as a means to decrease international HIV transmission...
  17. doi request reprint Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
    Am J Addict 17:116-20. 2008
    ..Serum transaminases remained stable from baseline. No serious adverse events related to treatment occurred. We conclude that select opioid-dependent patients exhibit moderate levels of retention in primary care office-based treatment...
  18. pmc Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone
    Jeanette M Tetrault
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    Alcohol Clin Exp Res 36:318-24. 2012
    ..We sought to determine the impact of naltrexone on hepatic enzymes and HIV biomarkers in HIV-infected patients...
  19. pmc Patient satisfaction with primary care office-based buprenorphine/naloxone treatment
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
    J Gen Intern Med 22:242-5. 2007
    ..Factors associated with satisfaction among patients receiving primary care-based buprenorphine/naloxone are unknown...
  20. pmc Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot study
    Brent A Moore
    Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, 495 Congress Ave, Second Floor, New Haven, CT 06519, USA
    J Addict Med 6:205-11. 2012
    ..Counseling and medication adherence can affect opioid agonist treatment outcomes. We investigated the impact of 2 counseling intensities and 2 medication-dispensing methods in patients receiving buprenorphine in primary care...
  21. pmc Opioids, chronic pain, and addiction in primary care
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    J Pain 11:1442-50. 2010
    ..Addressing these barriers to pain treatment will be crucial to improving pain management service delivery...
  22. pmc Integrating buprenorphine treatment into office-based practice: a qualitative study
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
    J Gen Intern Med 24:218-25. 2009
    ..Despite the availability and demonstrated effectiveness of office-based buprenorphine maintenance treatment (BMT), the systematic examination of physicians' attitudes towards this new medical practice has been largely neglected...
  23. pmc Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients
    Brent A Moore
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    J Gen Intern Med 22:527-30. 2007
    ..Prescription opioid dependence is increasing, but treatment outcomes with office-based buprenorphine/naloxone among these patients have not been described...
  24. ncbi request reprint Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520, USA
    N Engl J Med 355:365-74. 2006
    ..The optimal level of counseling and frequency of attendance for medication distribution has not been established for the primary care, office-based buprenorphine-naloxone treatment of opioid dependence...
  25. pmc HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study
    Frederick L Altice
    Yale University School of Medicine, New Haven, CT, USA
    J Acquir Immune Defic Syndr 56:S22-32. 2011
    ..Having opioid dependence and HIV infection are associated with poor HIV-related treatment outcomes...
  26. pmc A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    Am J Med 126:74.e11-7. 2013
    ..To determine the impact of cognitive behavioral therapy on outcomes in primary care, office-based buprenorphine/naloxone treatment of opioid dependence...
  27. ncbi request reprint Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates
    William C Becker
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, United States
    Drug Alcohol Depend 94:38-47. 2008
    ..Non-medical use of prescription opioids carries risks including development of abuse/dependence. Such use may correlate with psychiatric, medical, and substance use characteristics...
  28. pmc Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment
    Jeanette M Tetrault
    Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Addict Med 7:102-7. 2013
    ....
  29. pmc Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians
    E Jennifer Edelman
    Robert Wood Johnson Foundation Clinical Scholars Program, Yale School of Public Health, New Haven, CT 06520, USA
    J Addict Med 6:159-65. 2012
    ....
  30. ncbi request reprint Gender and non-medical use of prescription opioids: results from a national US survey
    Jeanette M Tetrault
    Veterans Affairs Clinical Epidemiology Research Center, West Haven, CT, USA
    Addiction 103:258-68. 2008
    ..Gender differences exist regarding alcohol and illicit drug use disorders in the United States. Little is known about the gender-related factors associated with non-medical use of prescription opioids...
  31. pmc Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone
    David A Fiellin
    Departments of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    J Acquir Immune Defic Syndr 56:S33-8. 2011
    ..Buprenorphine/naloxone allows the integration of opioid dependence and HIV treatment...
  32. ncbi request reprint The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention
    Frederick L Altice
    AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA
    Clin Infect Dis 43:S178-83. 2006
    ..Dialogue among practitioners and policy makers in the HIV care and substance abuse communities will facilitate an effective expansion of buprenorphine and ensure that these beneficial outcomes are achieved...
  33. pmc Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone
    Emily A Wang
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
    J Gen Intern Med 25:670-4. 2010
    ..Behaviors associated with opioid dependence often involve criminal activity, which can lead to incarceration. The impact of a history of incarceration on outcomes in primary care office-based buprenorphine/naloxone is not known...
  34. pmc Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications
    Emily A Wang
    Department of Internal Medicine, Yale University School of Medicine, Harkness Hall Building A 367 Cedar Street, Suite 410A, New Haven, CT 06510, USA
    J Gen Intern Med 26:1012-8. 2011
    ..The objective of this study was to examine the impact of food insecurity on HIV disease outcomes in a large cohort of HIV-infected patients receiving antiretroviral medications...
  35. doi request reprint Substance use in patients with sexually transmitted infections: results from a national U.S. survey
    Jeanette M Tetrault
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    Am J Addict 19:504-9. 2010
    ..A diagnosis of an STI should prompt clinicians to screen for substance use, in particular, alcohol abuse/dependence and marijuana use. ..
  36. pmc Evaluation of a combined online and in person training in the use of buprenorphine
    Erik W Gunderson
    Columbia University College of Physicians and Surgeon and New York State Psychiatric Institute, New York, NY, USA
    Subst Abus 27:39-45. 2006
    ..Overall, physicians preferred in person instruction and may benefit from additional experiential training and support after curriculum participation...
  37. pmc Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection
    Linda R Gowing
    University of Adelaide and Drug and Alcohol Services, South Australia, Australia
    J Gen Intern Med 21:193-5. 2006
    ..To assess the effects of oral substitution treatment for opioid-dependent injecting drug users on HIV risk behaviors and infections...
  38. pmc Update in addiction medicine for the generalist
    Adam J Gordon
    Mental Illness Research, Education, and Clinical Center, University of Pittsburgh, Pittsburgh, PA, USA
    J Gen Intern Med 22:1190-4. 2007